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1. Introduction 
Sepsis is defined as infection plus systemic manifestations of infection (Dellinger.R.P. et al. 
2008). Thus it is more than just the local organ pathology damage, and indicates malfunction 
of one or more other critical organs. There are few systematic reviews of what autopsy can 
contribute to sepsis studies, so this chapter attempts to summarise the main pathological 
concepts around sepsis with particular focus on diagnostic features – gross and 
histopathological - and differential diagnosis. The focus is information for practising 
pathologists. Currently, detailed non-forensic autopsy practice seems to have fewer 
enthusiasts than heretofore, and the case is made that in sepsis-related fatality, there is much 
to observe and learn. This chapter is a revision of an article on the autopsy and sepsis 
published in 2007 (Lucas 2007).  
Autopsy pathologists not infrequently use the term ‘septicaemia’ (implying blood infection) 
as the final process causing death, implying that there was bacteraemia – hopefully proven 
but sometimes assumed – associated with one or more organ failures. This is an uneasy 
combination of clinical, laboratory and gross pathological features, because:  
1. there are no specific morbid anatomical features of ‘septicaemia’  
• the historical ‘diffluent’ or ‘septic’ spleen is a debatable gross entity (Arismendi-
Morrillo et al. 2004) 
• ‘shock lung’ and ‘acute tubular necrosis’ are difficult to diagnose on gross 
examination alone 
2. the interpretation of pre-mortem, let alone post-mortem, blood cultures is not easy 
(Morris, Harrison, & Partridge 2006) 
3. there are no standard histopathological features that reliably point to ‘septicaemia’ 
4. there is no agreed case definition of ‘septicaemia’.  
It is more logical to consider ‘sepsis’: its local origins, systemic consequences, and degrees of 
severity.  
Within intensive care units (ICU), where most patients with severe sepsis are cared for 
(Dellinger et al. 2004), autopsy analysis still reveals previously unknown diagnoses that 
could, if treated differently, have altered the outcome; and this despite the panoply of 
investigative procedures now available to modern ICU medicine. From the 21st century, a 
USA study (Roosen et al. 2000) found 16% Goldman class 1 discrepancies (ie missed 
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opportunity to change therapy and prolong survival (Goldman et al. 1983)), and fungal 
infections were notably under-diagnosed pre-mortem. In a recent French study (Combes et 
al. 2004) 32% of autopsies showed Goldman class 1 or 2 discrepancies, particularly among 
the immuno-compromised patients. The diseases missed included cancer, stroke, 
myocardial infarction, endocarditis, and pulmonary embolism. A British study (Perkins et 
al. 2003) noted that only 7.7% of ICU deaths underwent autopsy, and found similar 
discrepancy patterns to the French study. What few of these studies address is the precise 
contribution of sepsis and its management to death, although severe sepsis is noted to be 
both under- and over-diagnosed pre-mortem (Blosser, Zimmerman, & Stauffer 1998) 
(Perkins, McAuley, Davies, & Gao 2003).  
1.1 The role of the autopsy in sepsis 
What can autopsy pathology – and pre-mortem cellular pathology – contribute to improving 
the care and outcomes of sepsis patients? There are three main categories of positive 
contribution: 
1. assisting in diagnosis pre-mortem, through tissue examination (histopathology and 
cytopathology (Schnadig, Molina, & Aronson 2007)) 
2. evaluating dead patients for actual clinico-pathological outcomes 
• confirming or refuting pre-mortem diagnoses  
• including potential complications of intensive care 
• identifying co-morbidities that affected recovery 
3. providing this information back to clinicians and IC units as monitoring and audit in 
order to feed into improving future managements 
The 2008 revision of the clinical Recommendations for Surviving Sepsis Campaign 
(Dellinger.R.P., Levy, Carlet, & et al 2008) can be scrutinized against possible contributions 
of pathology. For several of the Recommendations, autopsy pathology investigations can 
contribute nothing specifically: 
1. Initial Resuscitation 
2. Glucose Control 
3. Renal Replacement 
4. Bicarbonate Therapy 
5. Selective Digestive Tract Decontamination 
6. Consideration of Limitation of Support 
But for the other Recommendations, autopsy pathology can contribute significantly to the 
evaluation in their efficacy and complications: 
1. Diagnosis – of infections and co-morbidities 
2. Antibiotic Therapy – effectiveness of therapy, and potential toxic complications of 
therapy 
3. Source Control – as with Diagnosis of infections 
4. Fluid Therapy – overload, underperfusion 
5. Vasopressors & Inotrope Therapies – complications such as cardio-toxicity 
6. Corticosteroids – complications including opportunistic infections6 
7. Recombinant Activated Protein C – haemorrhagic complications 
8. Blood Product Administration – identification of Transfusion Associated Lung Injury 
(TRALI) 
9. Mechanical Ventilation of acute lung injury – the impact of tidal volume and O2 
concentration on alveolar membranes 
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10. Extracorporeal Membrane Oxygenation (ECMO) – its contribution to lung pathology 
(eg aspergillosis) 
11. Sedation – the issue of possible morphine toxicity 
12. Deep Vein Thrombosis Prophylaxis – its efficacy 
13. Gastric Stress Prophylaxis – its efficacy 
2. Epidemiology 
Epidemiologically, the incidence of severe sepsis (as defined below) in industrialised 
countries is 50-95 cases per 100,000 population and is rising by up to 9% each year, for 
reasons still unexplained. It accounts for 2% of hospital admissions in the USA, affecting 
about 700,000 people per year, causing death in 210,000; and is the tenth leading cause of 
death (Annane, Bellisant, & Cavaillon 2005) (Riederman, Guo, & Ward 2003) (Danai & 
Martin 2005) (Lever & Mackenzie 2007). 
3. Clinical case definitions 
As a result of consensus meetings in the early 1990s– intended to improve not only patient 
management but also the comparability of clinical trials in intensive care unit settings (ICU) 
– there are agreed clinical case definitions of sepsis, including severity and organ syndromes 
(see Table 1) (Riederman, Guo, & Ward 2003) (Levy & et al 1992). The recognition of the 
systemic inflammatory response syndrome (SIRS) is central to the definitions.  
 
Diagnosis Definition
SIRS (systemic inflammatory response 
syndrome) 
 
Temperature >38 deg C or <36 deg C 
Heart rate >90/min 
Systolic blood pressure <90mmHg 
Respiratory rate >20/min or PaCO2 
<32mmHg 
Blood white cell count >12x109/L or 
<4x109/L, or >10% immature band forms. 
Sepsis Systemic response to infection, as 
manifested by two of more of the above list 
(ie SIRS + infection).
Severe sepsis 
 
Sepsis with associated organ dysfunction, 
hypoperfusion, or hypotension including 
lactic acidosis, oliguria, or acute alteration 
in mental state.
Septic shock Sepsis-induced hypotension despite 
adequate fluid resuscitation, along with 
presence of severe sepsis.
MODS (Multiple organ dysfunction 
syndrome) 
The presence of altered organ function in 
an acutely ill patient such that homeostasis 
cannot be maintained without intervention. 
Table 1. Clinical definitions of sepsis  
The six most common sites of infection associated with sepsis are pneumonia, blood stream 
infections (including infective endocarditis), intravascular catheter-related sepsis, intra-
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abdominal infections, urological sepsis, and surgical wound infections. Florid septic shock 
syndromes also arise post-delivery, from necrotising fasciitis, and menstrual toxic shock 
syndrome (see Table 2). 
 
Syndrome Clinical features 
Meningococcal (Neisseria meningitidis) 
bacteraemic shock 
 
Disseminated intravascular coagulation 
prominent 
Haemorrhagic rash (see Figs 2 & 3) 
Mortality = 10-20% 
Staphylococcal (S.aureus) toxic shock 
syndrome 
 
Menstrual (tampon-related) 
Non-menstrual 
Skin wounds, surgical wounds 
Pneumonia 
Catheter infections 
Mortality = 5% 
Streptococcal (group A) toxic shock 
syndrome 
 
Deep seated infections 
Necrotising fasciitis 
Surgical operation sites 
Puerperal sepsis 
Mortality = 50% 
Table 2. The three most severe fulminant and toxic shock syndromes (TSS) and some of their 
characteristics (Munford 2005) (Moreillon, Que, & Glauser 2005) (Bisno & Stevens 2005).    
The staphylococcal and streptococcal TSS have a rapid onset because the bacteria secrete 
superantigens which directly activate T-cells, with release of much TNFα, and a rapid 
cytokine storm. 
Further consensus meetings have arrived at agreed organ-specific case definitions, with 
emphasis on the stringency of the clinical characteristics and the microbiological 
investigations (Calandra, Cohen, & et al 2005). Table 3 indicates that for pneumonia. 
4. Infections causing sepsis 
The spectrum of infections has changed. In the 1970-80s, gram-negative bacteria 
predominated. But in the 21st century, the in-hospital case pattern is (Annane, Bellisant, & 
Cavaillon 2005) (van der Poll.T & Opal 2008): 
• 25-30% gram-negative infections 
• 30-50% gram-positive infections 
• 25% polymicrobial infections 
• 25% multi-drug resistant organisms (eg MRSA and fungi) 
• 2-4% viral and parasitic infections (but probably underestimated) including malaria 
• eg HHV8/HIV co-infection (Fowler et al. 2006) 
• ~30% negative cultures: community-acquired sepsis treated with antibiotics before 
admission; and higher rates of negative cultures reported in neutropaenic sepsis.  
• Mycobacterium tuberculosis, particularly when it is anergic pattern due to host 
immunosuppression (see Figs 12 & 13). 
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Level of Certainty Definition 
Microbiologically 
confirmed (ie definite) 
• New or progressive radiological infiltrate 
• Clinical suspicion of pneumonia, or a Clinical 
Pulmonary Infection Score (CPIS) =>6; this six-feature 
scale includes identification of bacteria on gram stain 
of lower respiratory tract samples.  
• Identification of a pathogen – one or more of the 
following categories: 
a. Uncontaminated sample (blood, pleural fluid, 
transthoracic or transtracheal aspirate 
b. Respiratory secretions, not a pathogen that colonises the 
upper airways 
a. A likely pathogen using quantitative cultures of 
lower respiratory tract samples 
b. Positive infection serology 
Probable Clinically as above, but the identification of a pathogen is 
a. Below the diagnostic threshold, or 
b. Negative within 72 hours of starting a new 
antibiotic regime 
Possible Abnormal chest radiograph of uncertain cause in a patient 
with moderate or low suspicion of pneumonia, but with 
microbiological or serological evidence of definite or 
probable pneumonia (as defined above). 
Table 3. Pneumonia  case definitions 
The purpose of detailing these clinical case definitions is to contrast them with the morbid 
anatomical features of sepsis, which are less well depicted. Pathologists can assist clinical 
colleagues in evaluating patients dying of known or suspected sepsis, proving sepsis or 
identifying the differential diagnoses. They could thereby more usefully contribute to audit 
and the evaluation of novel therapies in sepsis.  
5. Pathogenesis of the sepsis syndromes 
SIRS is characterised as ‘an abnormal generalised inflammatory reaction in organs remote 
from the initial insult’ (Munford 2005). SIRS can result from non-infective causes, such as 
trauma, pancreatitis and cardiac-bypass procedures, and the pathologist needs to bear this 
in mind when evaluating deaths presented as ‘?sepsis’. 
Enormous research has gone into identifying the pathogenesis of the remote organ damage 
that characterises severe sepsis; three recent reviews (Munford 2005) (Calandra, Cohen, & et 
al 2005) (Annane, Bellisant, & Cavaillon 2005) (van der Poll.T & Opal 2008) (Lever & 
Mackenzie 2007) emphasise how much we do not understand. 
In brief, infections trigger a cytokine cascade via Toll-like receptors on inflammatory cells, 
with the excess secretion of many pro-inflammatory mediators including IL-1, TNFα, IL-6, 
nitric oxide (NO), platelet activating factor (PAF) (Mitchell 2005). Systemically, these affect 
organ function via damage to epithelia and endothelial cells (with abnormal 
microcirculation), inflammatory cell infiltration, initiation of the coagulation system, 
endocrine stimulation, and activation of the autonomic nervous system. The microbial 
www.intechopen.com
 Severe Sepsis and Septic Shock – Understanding a Serious Killer 
 
76
triggers include endotoxin (lipopolysaccharide) in gram-negative bacilli and superantigens 
in gram-positive cocci. The cholinergic nervous system appears to be important in that it 
suppresses the production of pro-inflammatory cytokines (van der Poll.T & Opal 2008).  
Modern thinking is that in the early phase of SIRS, the response is balanced and with 
elimination of the infection, there can be full recovery. But if the response is unbalanced, 
with over-production of inflammatory cytokines, the outcome is less good: acute organ 
dysfunction can result in early death; and if the lymphopaenia phase is associated with 
immune suppression (see below), then opportunistic infections contribute to the worsening 
mortality rates.  
Two underlying processes have been more recently highlighted in severe sepsis:  
i. there is apoptosis of lymphocytes in the spleen and gut (Hotchkiss et al. 1999). It is 
hypothesised that this leads to impairment of immune responses in sepsis, following 
the acute phase (van der Poll.T & Opal 2008).  
ii. organ failure is not always from observable necrosis and/or fibrosis (ie structural) but is 
functional. There is reduction in cellular mitochondrial activity, and this ‘hibernation’ 
may be a protective response (Singer et al. 2004) (Levy et al. 2005).  
There are significant controversies, including:  
1. the significance of bacteraemia: does this trigger severe sepsis, or is it a transient 
leakage phenomenon, and contribute little, per se, to outcome? 
2. the continuum of the sepsis syndromes: is this a true final common path, independent 
of the actual initiating infection? Or do different infection-host interactions produce 
severe sepsis and septic shock through different mechanisms? (Munford 2005).  
3. the concept that a major determining factor in patient outcome, for any given aetiology 
and set of co-morbidities, is not the particular therapy in ICU but the individual’s 
genetic make up (Annane, Bellisant, & Cavaillon 2005) (Villar et al. 2004)?  
4. The contribution of virulence factors in outcomes of sepsis (van der Poll.T & Opal 2008) 
5. it is not always evident grossly and histologically why patients with sepsis have died. A 
new paradigm is needed (Hotchkiss, Swanson, Freeman, & et al 1999).  
6. Autopsy protocols 
In the UK, >95% of adult autopsies are performed for a coroner, or (in Scotland) a 
procurator fiscal, under medico-legal conditions. Since the basic remit of the medico-legal 
autopsy is to exclude unnatural or violent death, and, if possible, to avoid having an inquest 
(National Confidential Enquiry into Patient Outcome and Death 2006), the level of detail of 
examination of cases that may have a sepsis syndrome is varied. Often the autopsy does not 
address the questions raised by the clinical course of the patient with sepsis. In this brief 
review, there is no attempt to address the requirements of what coroners might want from 
pathologists in ‘?sepsis’ cases.  
7. Microbiology sampling 
One of the problems in the septic autopsy is the lack of agreed methods of sampling blood, 
tissues and other fluids so that 
• Contamination from other organs is minimised 
• The consequences of the post-mortem spread of gut flora bacteria into the blood and 
tissues is minimised (Morris, Harrison, & Partridge 2006) 
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Also there are no agreed strategies of what to sample for each clinico-pathological-
microbiological scenario. In all cases, doing the sampling as soon after death as logistically 
feasible reduces the problems in the interpretation of bacterial culture results. See Table 4 for 
interim recommended practice. 
 
Tissue Sampling method
Cerebrospinal fluid With syringe and needle through alcohol-cleaned skin, 
through either or both of: 
• Cisternal puncture (posterior neck below the occipital 
protruberance; aim anteriorly for the eyes) 
• Lumbar puncture (between L4-5)
Urine 
 
Syringe and needle through cleaned suprapubic skin 
Blood 
 
Cardiac puncture blood, through the left 4th intercostals space, 
or peripheral venous blood 
• Subclavian vein (above clavicle), or 
• once the body is opened and before any organs 
opened or removed (particularly the intestines), tie 
off an iliac vein proximally, insert syringe needle 
pointing distally and withdraw 10 ml blood.  
Inoculate 5 ml into each of aerobe and anaerobe blood culture 
bottles.
Cardiac vegetations Divide between a sterile bottle for culture and histopathology. 
Lung tissue Attempts to sterilise the outer surface are probably futile. A 
compromise is to cut the lung with a clean organ-slicing blade 
on a clean surface and sample the relevant areas with a sterile 
scalpel blade.
Table 4. Sampling autopsy tissues for microbiological culture 
7.1 Interpretation of bacteriological cultures 
In all cases, the microbiology department must be advised what range of organisms is being 
sought; culture set-ups and molecular diagnostic techniques vary accordingly. 
Interpretation of positive results is often difficult, and consultation with an experienced 
microbiologist is critical. In cultures, confidence that the identified organism is significant is 
appropriate if there is Mycobacterium tuberculosis, Streptococcus group A (pyogenes), 
Streptococcus pneumoniae, or Neisseria meningitides since these are most unlikely to be present 
incidentally or from contamination. 
The introduction of the new molecular sepsis assay technologies for the rapid, sensitive and 
specific identification of bacterial species in blood and other samples may change much of 
this (Tissari et al. 2010). They have yet to be introduced into autopsy-related practice, and it 
will be important to determine whether they make simpler or more complicated the 
interpretation of post-mortem blood cultures.  
8. Non-microbiological means of identifying severe sepsis 
In many cases at autopsy, the need to confirm or exclude sepsis happens without positive 
microbiology, either because all attempts (including pre-mortem) were negative (perhaps 
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due to anti-microbial chemotherapy), or because samples were not taken at all. Where 
histological evidence of pyogenic infection with definite bacteria or fungi is present, this can 
indicate the organ-site of the sepsis.  
If no infection is identified, there is an immunocytochemical technique that may assist. In 
SIRS, endothelial cells are upregulated, and express cell more adhesion molecules such as 
ICAM-1 (intercellular adhesion molecule–1; CD54) and E-selectin (CD62E). It is possible to 
immunostain for these (Fig 1) and at least one author holds that positive ICAM-1 staining of 
alveolar capillary endothelial cells indicates septic shock with high sensitivity and specificity 
(Tsokos 2003).  
 
 
Fig. 1. Lung in septic shock, stained for CD54, showing endothelial cell (EC) upregulation 
(normal lung ECs do not stain).  
There are suggestive reports on the estimation of post-mortem serum endotoxin level as an 
indicator of sepsis (Zhu et al. 2005). 
9. Simulators of septic shock  
Patients with clinical manifestations similar to those of septic shock come to ICU and die 
despite empirical therapy. The differential diagnosis includes 
• Disseminated cancer, including carcinoma and lymphoma. For example, pulmonary 
micro-emboli from an occult carcinoma can obstruct pulmonary arterioles and cause 
cardio-respiratory failure (Hirata et al. 1988). 
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• Haemophagocytic syndrome 
• HHV8-associated multicentric Castleman disease syndrome in HIV-infected persons 
(Stebbing et al. 2011) 
• Thrombotic microangiopathy syndromes 
• Other conditions that mimic SIRS, but not considered in more detail (Munford 2005) 
• Multi-organ atherosclerosis, NO expression being a common factor 
• Burns 
• Adrenal insufficiency 
• Thyroid storm 
• Major trauma 
• Pancreatitis 
• Cardio-pulmonary bypass 
• Drug hypersensitivity reaction and acute anaphylaxis 
• Malignant hyperthermia and heat stroke 
10. Specific organs at autopsy 
The organ pathology of sepsis comprises gross and histopathological lesions. The 
histopathological lesions can often identify a specific infection, or at least point to a limited 
range of possible infectious agents (Table 5). ‘Pathology’ is, essentially, the study of host 
reaction to injury. Thus in the diagnosis of sepsis there are the  two complementary 
pathways for evaluating infectious disease: 
1. the gross pathology 
2. the microscopic pathology (histopathology and cytopathology), which is subdivided 
into: 
• identification and quantification of infectious agents 
• categorising the host inflammatory reaction, or absence of reaction 
Considering acute host inflammatory reactions, they can be considered as shown in Table 5. 
10.1 Heart 
The syndrome of sepsis-related myocardial dysfunction includes reduced left and right 
ejection fractions and elevated heart rate (Table 6) (Munford 2005). There is evidence of 
apoptotic damage to cardiac myofibres in the rodent model of sepsis (Ha et al. 2006). But the 
clinical experience of patients surviving sepsis is that there is no evidence of persistent 
cardiac defects attributable to such a process. Presumably, the dysfunction is cytokine 
driven and reversible (Levy, Piel, ACton, & et al 2005). The heart in autopsied non-survivors 
shows prominent interstitial mononuclear cells – this is not myocarditis but mainly 
enlargement of capillary endothelial cells, as part of the generalised endothelial up-
regulation phenomenon. 
Given the generally old age of patients admitted to ICU with sepsis, many will have 
coronary artery disease, with or without previous myocardial infarction, at autopsy. The 
extent to which this contributes (if at all) to death needs to be carefully considered in the 
context of the whole case. The Davies scale of certainty for ischaemic heart disease death 
(although designed for sudden cardiac death in the community) is a bench-mark from 
which to work (Royal College of Pathologists 2005). Nothing irritates ICU clinicians more 
than to be told that the cause of death was ‘ischaemic heart disease’ in a complex case of  
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Pattern of inflammation Quantity of 
infectious 
agent 
Example 
Haemorrhage only - to +++ Anthrax, streptococcal skin rash 
Minimal inflammation +++ 
Neutropaenic sepsis 
(many bacteria types, including 
anergic tuberculosis) 
Usual acute inflammation - to +++ 
Pneumococcus, other 
streptococci, gram-ve bacilli, 
anergic tuberculosis 
No inflammation; vasculopathy 
and necrosis 
+++ 
Pseudomonas vasculitis, 
toxoplasmosis 
Necrosis and inclusion bodies 
(intranuclear and/or 
intracytoplasmic) 
+ to +++ 
Virus infections: herpes, Ebola 
Mixed granulomatous and acute 
inflamation 
- to +++ 
Melioidosis, tularaemia, typhoid 
Chronic inflammation - to + Chagas’ disease 
Necrosis, no inflammation +++ 
Strep.pyogenes (necrotising 
fasciitis), Clostridium perfringens, 
leptospirosis 
Vasculitis and thrombosis + to +++ 
Pseudomonas, meningococcus 
(Fig 2,3) 
Botryomycosis +++ Staphylococcus aureus 
No inflammation, parasites in 
vessels 
+ to +++ 
Malaria 
 
 
 
 
 
 
Table 5. Some consistent patterns of inflammation associated with particular infections  
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multi-organ failure and sepsis. If the patient was part of a therapeutic protocol trial, it is 
even more unfortunate, as the aspects of apparent therapy failure will be mis-apportioned.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Skin in a fatal case of meningococcal sepsis. The artery is vasculitic and thrombosed 
(H&E) 
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Fig. 3. Same vessel as in Fig 2, stained with Brown-Hopps gram stain, to demonstrate gram-
ve cocci in the lumen and endothelium  
 
 Ischaemic 
Necrosis 
(atonic 
fibres) 
Contraction 
band 
necrosis 
(hyper-
contracted 
fibres) 
Interstitial 
inflammation
Myocarditis Interstitial 
haemorrhage 
Myocardial 
Infarction 
+ - - - + 
Re-perfusion 
Injury 
+ + - - + 
Inotropes & 
cocaine 
+ + - - - 
Sepsis +/- - + +/- + 
Infective 
endocarditis 
+/- - + + - 
Cardio-
pulmonary 
resuscitation 
+ + - - + 
Table 6. Cardiac pathologies encountered in ICU patients and sepsis syndromes (Baroldi 
2006) ; (Nishida et al. 2006) 
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10.1.1 Heart examination 
Given the subtle nature of cardiac lesions in sepsis and its treatment, there is an argument 
for proper histopathological examination of a complete horizontal slice, with a minimum of 
5 blocks taken: 2 from the right ventricle in one block, and one full thickness section from 
each left ventricular quadrant (Royal College of Pathologists 2005).  
10.2 Brain 
At the gross and standard microscopic level, the brain is not directly affected by sepsis and 
septic shock. This matches the lack of imaging-detected damage despite the common clinical 
cognitive and performance deficiencies (Munford 2005), and is presumably a transient 
cytokine-based phenomenon. However, certain cerebral pathologies are associated with 
sepsis syndromes for more tangible reasons, including: 
• Cerebral infarction from thrombo-embolisation 
• Hypoxic-ischaemic encephalopathy (HIE) following temporary cessation of blood 
and/or oxygen supply during a crisis 
• Metastatic cerebral abscess and/or meningitis from a remote focus of sepsis 
• Microinfarction from thrombotic microangiopathy affecting all areas of the brain 
In the case of HIE, post-mortem pathology does not form part of the case definition, which is 
solely clinical, neurophysiological and radiological. The most sensitive zones of the brain for 
such damage are the cerebellar nuclei and the hippocampus, followed by the cerebral cortex 
in the watershed areas at the junctions of the cerebral artery supply zones. It is useful to 
sample these to confirm HIE, and to be aware of the problem with artefacts (Whitwell 2005) 
10.3 Lung 
Lung dysfunction at the commencement of severe sepsis is present in about 20% of such 
patients (Munford 2005).The clinical diagnosis of acute lung injury is made when there 
arterial hypoxaemia (PaO2/FiO2<300mmHg) and bilateral chest pulmonary infiltrates on 
chest X ray, in the absence of pneumonia or heart failure. It becomes acute respiratory 
distress syndrome (ARDS) when hypoxaemia is more severe (PaO2/FiO2<200mmHg). 
Ventilation/perfusion mismatch (effectively right-to-left shunting) of blood flow occurs, 
exacerbating the hypoxaemia.   
Pathologically, the process is diffuse alveolar damage (DAD). This is not specific to the 
sepsis syndromes as it also occurs in inhalational injury (smoke, toxic gases, oxygen in high 
concentration), aspiration of gastric contents, and X-irradiation damage; these represent 
direct damage to the lung tissue. DAD also follows from remote injury as part of SIRS, the 
pathogenesis being mediators in the blood stream; the causes include cytotoxic drug 
therapy, pancreatitis, cardio-pulmonary bypass, blood transfusion reaction, fat embolism, 
paraquat poisoning, and systemic shock from any cause (Corrin & Nicholson 2011). 
Reduction of surfactant through epithelial cell damage is a key event, which leads to further 
alveolar and alveolar duct damage.  
DAD goes through stages termed the exudative, regenerative, and repair phases.  
The exudative phase lasts up to a week, and grossly the lungs are dark red and heavy. The 
early stage histologically comprises: 
• Alveolar wall congestion and expansion 
• Variable neutrophils in the interstitium (usually not) 
• Oedema and red cells in the alveolae 
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• Type 1 epithelial cell and alveolar capillary endothelial cell damage (but this is difficult 
to identify on light microscopy) 
The later exudative phase is the classic and, histologically, readily identifiable stage often 
termed ‘shock lung’ (Fig 4): 
• Alveolar collapse, haemorrhage and oedema 
• Hyaline membrane formation on the epithelial surface of respiratory bronchioles and 
alveolar ducts: this comprises fibrin and necrotic epithelial cells 
• Variable neutrophil accumulation in alveolar capillaries 
 
 
Fig. 4. Hyaline membrane disease in the lung alveoli in septic shock; the pink membranes 
are partly fibrin exudates and partly necrotic epithelium (H&E) 
The regenerative phase permits healing and recovery of the lung to normal structure or 
progresses to fibrosis via the repair phase. Type 2 epithelial cells proliferate to replace the 
denuded epithelium; they may be large and elongated, resembling macrophages in the 
airways. The epithelium may regrow beneath the hyaline membrane, which is sloughed off; 
or over the membrane, in which case it becomes incorporated into the alveolar wall and is a 
mechanism for interstitial fibrosis. In the capillaries, the endothelial repair may be 
accompanied by local thrombosis, organisation and local vascular remodelling.  
The repair phase occurs in those whose DAD has not resolved through regeneration.  
As well as the progressive interstitial thickening from incorporation of hyaline 
membranes and the ingress of fibroblasts into this tissue, the alveolar exudates organise. 
There are granulation tissue buds in the alveoli, as seen in organising pneumonias. This 
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fibrosis can happen within a few weeks, if the patient is maintained and alive (Vincent & 
Singer 2010). 
In practice, if patients survive long periods in ICU with episodes of severe sepsis and 
infective pneumonia and have been mechanically ventilated for long periods, the resulting 
lung tissue at autopsy can show a varied pattern with some areas of nearly normal tissue, 
organising pneumonia and interstitial fibrosis separately and combined: it can be difficult if 
not impossible to ascribe specific aetio-pathogeneses to this end-stage lung fibrosis (Fig 5).  
 
 
Fig. 5. Acute lung injury that has gone on to organisation with fibrosis, obliterating the 
alveoli (H&E). 
It is unresolved why some patients with DAD in whom the infecting agent is identified and 
treated promptly still go on to the repair phase and died of pulmonary fibrosis (Wheeler & 
Bernard 2007). This is particularly seen in patients presenting as advanced HIV disease with 
Pneumocystis infection, and despite co-trimoxazole plus steroid cover become progressively 
hypoxic; at autopsy the lungs show combined intra-alveolar and interstitial fibrosis.  
10.3.1 Ventilator-associated pneumonia (VAP) 
VAP is an important entity in ICU, as the development of lung infection during respiratory 
support demands a change in therapy. There have been several studies of the diagnostic 
criteria for VAP in vivo (microbiology and cytopathology) and at autopsy (histopathology), 
and the results are unsettling (Corley et al. 1997) (4177): 
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• There are no agreed criteria for diagnosing pneumonia in man by histology 
• Pathologists do not agree amongst themselves whether there is pneumonia or not 
• Quantitative pre-mortem bacteriology does not correlate with clinical symptoms or 
autopsy histopathology 
• Bronchiolar lavage fluid with few neutrophils does correlate with absence of 
histological pneumonia 
Evidently pathology is not yet serving clinical science optimally in this area. 
10.3.2 Neutropaenic sepsis 
This is a common terminal condition in patients with treated cancer. Bacteria proliferate in 
many organs and blood vessels, and in the lung they are visible in the alveoli with fibrin and 
mononuclear cells (Fig 6). 
 
 
Fig. 6. Lung alveoli in neutropaenic sepsis. There are abundant bacteria in the lumens, some 
haemorrhage, but only scanty inflammation (H&E) 
10.4 Liver 
The liver in septic shock has no specific features (Table 6). Clinically, there is cholestatic 
jaundice. If the source of the sepsis is the biliary tract (cholangitis) there may be abscesses 
centred on portal tracts. Otherwise, the liver is usually heavier than normal, bile stained, 
and soft. Histologically, autolysis with cell plate separation is often more advanced than 
expected from the time since death (perhaps due to high levels of TNFα). There is often fatty 
change, but usually little parenchymal inflammation, although the sinusoid Kupffer cells 
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and endothelial cells are prominent, and there may haemophagocytosis. Centriacinar 
necrosis is often prominent. 
Several patterns of bile duct histopathology are described, although none are specific to 
sepsis (Scheuer & Lefkowitch 2006):  
• Intracanalicular cholestasis in the perivenular areas 
• Ductular cholestasis, proliferating ductules, and surrounding portal neutrophilic 
inflammation, in addition to canalicular cholestasis 
• Non-bacterial cholangitis, with proliferating bile ductules; this is seen in the toxic shock 
syndrome (Fig 7). 
 
 
Liver 
abscess 
Bacterial 
cholangitis 
Bile duct 
obstruction 
Severe sepsis patterns 
Canalicular 
cholestasis 
Ductular 
cholestasis & 
inflammation 
Non-
bacterial 
cholestasis 
Perivenular 
cholestasis 
+/- - + + + - 
Canal of Hering & 
ductular cholestasis 
- - - - + - 
Ductular 
proliferation 
- + + - + + 
Ductular acute 
inflammation 
+/- + +/- - + + 
Parenchymal 
necrosis 
+ + +/- - - - 
Table 6. Liver histopathology in sepsis 
10.5 Kidney 
Acute renal failure occurs in one fifth of patients becoming septic, rising to 50% in septic 
shock (Munford 2005) (Racusen & Kashgarian 2007). It is the commonest organ dysfunction, 
manifesting as oliguria and azotaemia. The pathogenesis of the damage in sepsis includes 
systemic hypotension, renal vasoconstriction, toxic drugs (eg antibiotic aminoglycosides), 
and inflammatory cytokines.  
The pathological lesion is acute tubular injury (ATI), which replaces the older term ‘acute 
tubular necrosis’ (Racusen & Kashgarian 2007). Grossly the kidneys are enlarged 
(oedematous cortex) and typically pale, with blurred cortico-medullary junctions. Focal 
pyaemic lesions, ascending acute pyelonephritis lines, and (where arterial thrombi are 
formed) regional cortical infarctive necrosis may also be seen in some cases.  
ATI can only be reliably evaluated microscopically. The glomeruli may be collapsed but 
otherwise show no damage. The tubular damage is conceptually divided into ‘ischaemic’ 
and ‘toxic’ (Racusen & Kashgarian 2007), with more extensive proximal tubule lesions, and 
more evident cell death, in the latter. In septic shock, with the aetio-pathogenesis often 
multi-factorial, the distinction becomes blurred. Moreover, autopsy kidneys are notoriously 
autolysed unless analysed rapidly after death. The main features of ATI are (Fig 8): 
• Interstitial oedema with separation of tubules 
• Tubular cell swelling 
• Loss of nuclei of tubular cells or apoptosis 
• Shedding of tubule cells into the lumen 
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Fig. 7. The portal ductular prolferative reaction in systemic sepsis, with inflammation (H&E) 
• Attenuation of the tubular epithelium thickness 
• Regeneration of tubular cells: hyperchromatic enlarged nuclei, often adjacent; mitoses 
• Insignificant interstitial inflammation 
• Accumulation of nucleated cells in the vasa recta in the outer medulla; lymphocytes, 
myeloid precursors, and nucleated red cell precursors 
All too often, the time delay to autopsy precludes confirmation of these features through 
autolysis. Microvesicular vacuolation of proximal tubules is not ATI, but the result of 
medical drugs and dextrose-containing plasma expanders. 
10.6 Adrenal glands 
The adrenals may show the following features 
• Lipid depletion and hyperplasia 
• Atrophy (if prolonged steroid therapy has been given) 
• Parenchymal haemorrhages, small or large 
• Thromboses in small arterioles 
11. Haemophagocytic syndromes 
There is a group of conditions termed ‘haemophagocytic syndromes’ (HPS) where the 
driving process is excessive phagocytosis of formed blood cells by macrophages in the 
marrow, spleen and lymph nodes (Fig 9). The clinical outcomes include: 
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Fig. 8. Kidney in acute tubular necrosis (acute tubular injury). The necrosing epithelium is 
sloughing into the lumen (H&E) 
• High fever 
• Pancytopaenia 
• Liver dysfunction 
• Clotting abnormalities including raised fibrin degradation products and 
hypofibrinogenaemia 
• Hepatosplenomegaly 
• Hyperferritinaemia 
Thus HPS overlaps clinically with septic shock by case definition (Fisman 2000). The 
mortality is high, up to 70% (Takahashi et al. 2001) (Ningsanond 2000) From personal 
experience, many cases that turn out to be HPS have been patients presenting acutely with 
SIRS, infection screens are negative, and the patients die within a week, of multi-organ 
failure, despite antibiotics, steroids and standard ICU support procedures.  
The pathogenesis of HPS is considered to be an aberrant immunological over-reaction, the 
hyperstimulation of macrophages by cytokines (particularly TNFα, IL-6, IL-1 and IFNγ) as 
result of T-cell activation. In addition to a rare familial HPS, the aetiologies include 
infections, autoimmune disease (particularly SLE) and lymphoma (particularly T-cell 
lymphoma, but also B-cell). The potential causative infections are legion (Takahashi, 
Chubachi, Kume, & et al 2001) (Ningsanond 2000) (Fisman 2000): 
• Viral – eg EBV, HHV8, HIV (multi-centric Castleman disease), CMV, B19, rubella, viral 
hepatitis 
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• Bacteria – eg pneumococcal, typhoid 
• Mycobacteria – tuberculosis 
• Fungi – eg histoplasmosis 
• Protozoa – eg leishmaniasis 
Bone marrow haemophagocytosis is found in one third of ICU non-survivors, associated 
positively with sepsis and blood transfusion, and negatively with cardiovascular disease 
(Stauss et al. 2004). Thus the distinction between a non-specific reactive process and a 
syndrome is currently blurred.  
 
  
Fig. 9. Bone marrow with haemophagocytosis. Left: numerous large macrophages with 
engulphed red cells and nuclei (H&E).  Right: CD68 immunostaining to highlight the excess 
number of large macrophages.  
12. Thrombotic microangiopathy syndromes 
Thombi are frequently encountered in small vessels in sepsis and other conditions. The 
thrombi are composed of fibrin and platelets in varying proportions. There are two groups 
of conditions to consider: disseminated intravascular coagulation (DIC) and thrombotic 
microangiopathy (TTP variant).  
12.1 Disseminated intravascular coagulation (Toh & Dennis 2003) 
The thrombi are predominantly composed of fibrin and it is accompanied by 
coagulopathy with depletion of coagulation factors in the blood. DIC (as defined by 
laboratory criteria) occurs in up to half of patients with severe sepsis (van der Poll.T & 
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Opal 2008). The pathogenesis is not well understood but may be endothelial injury and 
the expression of tissue factor on infected monocytes, and initiation of the clotting cascade 
(Munford 2005). With the exception of meningococcal septicaemia, autopsy studies do not 
show a correlation of organ dysfunction and deposition of microthrombi in DIC. When 
thrombi are seen, the kidney glomeruli and lung alveolar capillaries are the commonest 
location (Fig 10). 
 
 
Fig. 10. DIC in pneumococcal sepsis. In this renal glomerulus, all the capillaries are blocked 
by thrombi (H&E).  
Neisseria meningitidis infection causes a fulminant meningococcaemia (and this is often 
found without a meningitis). Here DIC is the norm, and bacteria may be found within 
dermal vessels (Fig 3). Meningococci are different from other gram-negative bacilli as they 
shed membrane blebs that active complement and coagulation directly. Widespread skin 
and internal organ haemorrhages are seen, associated with small vessel DIC, and the 
adrenal shows haemorrhages (though rarely a massive destructive haematoma).  
A prototype TMA is thrombotic thrombocytopaenic purpura (TTP) and the related 
haemolytic uraemic syndrome (Hosler, Cusumano, & Hutchins 2003). Unlike DIC, the 
clotting factors are not affected, and the thrombi are predominantly platelets. Clinically 
TMA may simulate septic shock. Using immunocytochemistry to quantify fibrin versus 
platelets (anti-fibrin and anti-CD61 antibodies respectively) and thus distinguish TMA from 
DIC is not always helpful: the staining intensities can be similar in both conditions. 
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13. End-stage liver disease (ESDL) 
The adverse impact of cirrhosis is well-attested in many medical and surgical conditions. 
The Child-Pugh liver score (a measure of hepatic and extra-hepatic dysfunction based on 
combined biochemical markers and clinical signs) predicts non-survival in cirrhotic patients 
admitted to ICU. Overall, the one-year mortality of such patients is 69-74%, with median 
survival of one month (Gildea et al. 2004) (Arabi et al. 2004).  
Cardiac operations are hazardous in cirrhotic patients, with those on cardio-pulmonary 
bypass particularly liable to die (Hayashida et al. 2004) and – if they are Child-Pugh class C 
– approach a 100% mortality. Similarly, abdominal trauma patients have ICU post-operative 
mortality rates increasing from 15-63% as the severity liver failure increases (Christmas et al. 
2005). In these patients a major cause of death is sepsis and septic shock. The abnormal 
blood circulation to cirrhotic liver tissue renders the Kupffer cell macrophages less able to 
clear bacteria from the blood. 
It is the experience of pathologists examining patients who die in ICU that cirrhosis is 
significantly under-diagnosed pre-mortem, and that clinicians would like better methods 
of identifying the patients who have cirrhosis. There are several implications. First, 
consider liver disease carefully in ICU and sepsis deaths. The eyeball confident diagnosis 
of cirrhosis - or not - is not always possible. Secondly, in the formulation of cause of death 
in these cases, ‘cirrhosis’ should be included as a contributor to mortality in the death 
certificate.  
Thirdly, liver biopsy is the only pre-autopsy definitive marker of liver fibrosis and 
cirrhosis; but it is invasive and has a mortality rate. Imaging, standard biochemical tests, 
serum markers of fibrosis, and more specialised tests of liver function only identify a 
proportion of cirrhotic patients (Rockey & Bissell 2006), and these non-invasive tests have 
not been validated for ‘normal’ patients about to undergo cardiac surgery or those already 
in ICU for other reasons. Further research into better indicators of cirrhosis is urgently 
needed.  
14. Outcomes and co-morbidities 
Mortality in patients with septic shock is highly variable, from 35-70% depending on many 
variables that include (Annane, Bellisant, & Cavaillon 2005) 
• age & sex 
• co-morbidities and other altered physiological states 
• sickle cell disease and other hyposlenic states (Di Sabatino, Carsetti, & Corrazza 
2011) 
• immunosuppression (Morris, Masur, & Huang 2006) (Combes, Mokhtari, 
Couvelard, & et al 2004) 
• chronic obstructive pulmonary disease 
• ischaemic heart disease  
• end-stage liver disease 
• pregnancy 
• the combined total of failing organs, particularly lung and kidney 
• whether the infection is nosocomial or polymicrobial 
• whether the infection is a fungus 
• ethnicity and inherited variables (Villar, Maca-Meyer, Perez-Mendez, & Flores 2004) 
www.intechopen.com
 The Autopsy Pathology of Sepsis-Related Death 
 
93 
14.1 Pregnancy 
The subject of susceptibility to infection during pregnancy is under-investigated 
epidemiologically. The depressed cell-mediated immunity during gestation does predispose 
to certain infections such as tuberculosis, Listeria and some viral infections. But despite the 
importance of bacterial infections in peri-partum sespsis, particularly Streptococcus pyogenes, 
it is unclear whether the pregnant state per se confers an increased susceptibility to them 
(Lucas 2011).  
15. The treatment of sepsis 
ICU treatment of patients in sepsis and shock has four main approaches 
• Anti-microbial therapy of known or suspected infective agents 
• Failing organ support – eg pulmonary, renal, hepatic, cardiac 
• Indirect therapies aimed at the systemic inflammatory response and its consequences: 
immunomodulatory and anti-inflammatory therapies 
• Surgical treatment – excision of septic foci and removal of necrotic tissue (eg infarcted 
bowel, necrotising fasciitis) 
As well as inotropic and renal support, a major function of ICU is ventilatory support. In 
DAD, the alveoli shut down on expiration and require a higher pressure to re-open. 
Mechanical ventilation thus exerts its stresses on the delicate lung tissue. Tidal volumes 
appear to be a critical variable in the causation of lung damage (Wheeler & Bernard 2007). In 
conjunction with the high oxygen concentration required to keep a reasonable blood PO2, 
this can further damage the lung.  
15.1 Specific drug treatments in sepsis 
Many trials of anti-inflammatory chemotherapy have been held in septic shock, including 
against (Riederman, Guo, & Ward 2003): immune regulation, endotoxin, TNFα, NO, IL-1, 
oxidants, neutrophil activity, complement, and coagulation. In practice, only steroid therapy 
and activated protein C (APC) have been validated as useful in improving survival. The 
reasons why the other therapeutic avenues have not proven successful include a) non-
homogeneity of the study populations, and b) the ill-understood multifactorial complexity 
of the sepsis syndromes. However, newer approaches to suppressing pro-inflammatory 
processes are being experimented with, such as anti-HMGB1 antibodies; these could 
suppress the late-acting pro-inflammatory cytokine High-Mobility Group Box-1 protein. It is 
know that this increases survival in the caecal puncture model of sepsis (van der Poll.T & 
Opal 2008).  
Steroid therapy has its known complications. APC acts as an anti-coagulant (thus 
important in DIC) as well as an inhibitor of production of IL-1, IL-6 and TNFα. The side 
effects are intracerebral (Recombinant human Protein C Worldwide Evaluation in Severe 
Sepsis (PROWESS) study group. 2001) and pulmonary haemorrhage (personal 
observations) (Fig 11). Another specific complication in modern chemotherapy is the 
increased susceptibility to certain pathogens with immunodulatory drugs.  An example is 
the negative impact of adalimumab if the patient has tuberculosis as a co-morbidity 
(Lever & Mackenzie 2007).  
The known increase in apoptosis in the lymphoid population (Hotchkiss, Swanson, 
Freeman, & et al 1999) has prompted consideration of anti-apoptotic chemotherapy. 
However, the potential of uncontrolled cell growth has to be evaluated first. 
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Fig. 11. Lung with massive haemorrhage, associated with administration of activated 
protein C in a patient with sepsis (H&E) 
An epidemiological analysis of outcomes in cardiovascular disease patients demonstrated 
that statin therapy was associated with reduced rates of sepsis and fatality from sepsis 
(Hackam et al. 2006). As well as being lipid-lowering agents, statins have many other effects: 
anti-inflammatory, modulation of cellular immunity, improvement of endothelial cell 
function, and increasing the bio-availability of NO. Apart from suggesting further strategies 
in sepsis therapy, this observation reminds pathologists to look at the treatments patients 
are on when they undergo autopsy.  
16. Conclusion 
This brief review of septic shock autopsy pathology and its differential diagnosis has 
focussed on the major conditions. There are less obvious pathologies whose contribution to 
the disease and outcome are uncertain. For example, apoptosis of neurones and glial cells in 
the cardiovascular centres of the brain. Patients who died of septic shock showed more such 
apoptosis in the amygdala and medullary autonomic nuclei than those dying of non-septic 
shock and sudden extra-cranial trauma. This was strongly associated with endothelial iNOS 
expression (Sharshar et al. 2003). Does this significantly contribute to outcome over and 
above direct organ damage?  
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In conclusion, there is much to be studied still in the morbid anatomy of sepsis syndromes. 
If pathologists are to be useful in sepsis research, careful documentation of autopsy organ 
pathology and microbiology, and the correlation of outcome with clinical features and the 
various therapeutic modalities, is essential.  New treatments for severe sepsis are being 
trialled to raise the poor survival rates in intensive care. The role of the autopsy is thus 
threefold: to describe carefully the organ lesions and identify microbiological agents directly 
and through the particular host reactions (Table 5; Fig 12,13); to identify co-morbidities and 
complications of treatments; and to collaborate with clinicians in audit and improving the 
outcomes of septic patients.  
 
 
 
 
 
 
 
 
Fig. 12. Autopsy lung of an HIV+ve patient who died with lung and multi-organ failure of 
uncertain aetiology. The lung alveoli are filled with granular necrotic debris and minimal 
cellular reaction. This is non-reactive (anergic) tuberculosis infection – see Fig 13 (H&E).  
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Fig. 13. Same lung as in Fig 12. The Ziehl-Neelsen stain reveals huge numbers of acid-fast 
bacilli. The ‘granular debris’ seen in Fig 12 H&E stain is comprised of clumped bacilli.  
17. References 
Annane, D., Bellisant, E., & Cavaillon, J.-M. 2005, "Septic shock", Lancet, vol. 365, pp. 63-78. 
Arabi, Y., Ahmed, Q. A., Haddad, S., Aljumah, A., & Al-Shimemeri, A. 2004, "Outcome 
predictors of cirrhosis patients admitted to the intensive care unit.", European 
Journal of Gastroenterology & Hepatology, vol. 16, pp. 333-339. 
Arismendi-Morrillo, G. J., Briceno-Garcia, A. E., Romero-Amaro, Z. R., & et al 2004, "Acute 
non-specific splenitis as indicator of systemic infection. Assessment of 71 autopsy 
cases.", Invest.Clin., vol. 45, pp. 131-135. 
Baroldi, G. 2006, "Basic pathophysiologic changes," in Pathology of the Heart and Sudden Death 
in Forensic Medicine, V. Fineschi, G. Baroldi, & M. D. Silver, eds., CRC Press, Taylor 
& Francis Group, Boca Raton, Fl, pp. 31-76. 
Bisno, A. K. & Stevens, D. L. 2005, "Streptococcus pyogenes," in Mandell, Douglas, and Bennett's 
Principles and Practice of Infectious Diseases, 6 edn, G. L. Mandell, J. E. Bennet, & R. 
Dolin, eds., Elsevier Churchill Livingstone, Philadelphia, pp. 2362-2379. 
Blosser, S. A., Zimmerman, H. E., & Stauffer, J. L. 1998, "Do autopsies of critically ill patients 
reveal important findings that were clinical undetected?", Critical Care Medicine, vol. 
26, pp. 1332-1336. 
www.intechopen.com
 The Autopsy Pathology of Sepsis-Related Death 
 
97 
Calandra, T., Cohen, J., & et al 2005, "The International Sepsis Forum Consensus Conference 
on Definitions of Infection in the Intensive Care Unit.", Critical Care Medicine, vol. 
33, pp. 1538-1548. 
Christmas, A. B., Wilson, A. K., Franklin, G. A., & et al 2005, "Cirrhosis and trauma: a deadly 
duo.", American Surgery, vol. 71, pp. 996-1000. 
Combes, A., Mokhtari, M., Couvelard, A., & et al 2004, "Clinical and autopsy diagnoses in 
the intensive care unit: a prospective study.", Archives of Internal Medicine, vol. 164, 
pp. 389-392. 
Corley, D. E., Kirtland, S. H., Winterbauer, R. H., & et al 1997, "Reproducibility of the 
histologic diagnosis of pneumonia among a panel of four pathologists.", Chest, vol. 
112, pp. 458-465. 
Corrin, B. & Nicholson, A. G. 2011, "Diffuse alveolar damage," in Pathology of the Lung, 3 edn, 
B. Corrin & A. G. Nicholson, eds., Churchill Livingstone, Elsevier, London, pp. 131-
149. 
Danai, P. & Martin, G. S. 2005, "Epidemiology of sepsis: recent advances.", Current Infectious 
Disease Reports, vol. 7, pp. 329-334. 
Dellinger, P., Carlet, J. M., Masur, H., & et al 2004, "Surviving Sepsis Campaign guidelines 
for management of severe sepsis and septic shock.", Critical Care Medicine, vol. 32, 
pp. 858-878. 
Dellinger.R.P., Levy, M. M., Carlet, J. M., & et al 2008, "Surviving sepsis campaign: 
international guidelines for management of severe sepsis and septic shock: 2008", 
Critical Care Medicine, vol. 36, pp. 296-327. 
Di Sabatino, A., Carsetti, R., & Corrazza, G. R. 2011, "Post-splenectomy and hyposplenic 
states.", Lancet, vol. 378, pp. 86-97. 
Fisman, D. N. 2000, "Hemophagocytic syndromes and infection.", Emerging Infectious 
Diseases, vol. 6, pp. 601-608. 
Fowler, A., Collins, L., de Ruiter, A., & et al 2006, "Multicentric Castleman's disease in a 
patient with HIV.", International Journal of STD and AIDS, vol. 17, pp. 63-64. 
Gildea, T. R., Cook, W. C., Nelson, D. R., & et al 2004, "Predictors of long-term mortality in 
patients with cirrhosis of the liver admitted to a medical ICU.", Chest, vol. 126, pp. 
1598-1603. 
Goldman, L., Sayson, R., Robbins, S., Cohn, L. H., Bettman, M., & Weisberg, M. 1983, "The 
value of the autopsy in three medical eras.", New England Journal of Medicine, vol. 
308, pp. 1000-1005. 
Ha, T., Grant, D., Xia, Y., & et al 2006, "Glucan phosphate attenuates cardiac dysfunction 
and inhibits cardiac MIF expression and apoptosis in septic mice.", American Journal 
of Physiology Heart Circulatory Physiology, vol. 291, p. H1910-H1918. 
Hackam, D. G., Mamdani, M., Li, P., & Redelmeier, D. A. 2006, "Statins in patients with 
cardiovascular disease: a population-based cohort analysis.", Lancet, vol. 367, pp. 
413-418. 
Hayashida, M., Shoujima, T., Teshima, H., & et al 2004, "Clinical outcome after cardiac 
operations in patients with cirrhosis.", Annals of Thoracic Surgery, vol. 77, pp. 500-
505. 
Hirata, K., Miyagi, S., Tome, M., & et al 1988, "Cor pulmonale due to tumour cell 
microemboli.", Archives of Internal Medicine, vol. 148, pp. 2287-2289. 
www.intechopen.com
 Severe Sepsis and Septic Shock – Understanding a Serious Killer 
 
98
Hosler, G. A., Cusumano, A. M., & Hutchins, G. M. 2003, "Thrombotic thrombocytopenia 
purpura and hemolytic uremic syndrome are distinct pathologic entities. A review 
of 56 autopsy cases.", Archives of Pathology and Laboratory Medicine, vol. 127, pp. 834-
839. 
Hotchkiss, R. S., Swanson, P. E., Freeman, B., & et al 1999, "Apoptotic cell death in patients 
with sepsis, shock, and multiple organ dysfunction.", Critical Care Medicine, vol. 27, 
pp. 1230-1251. 
Lever, A. & Mackenzie, I. 2007, "Sepsis: definition, epidemiology, and diagnosis", Bmj, vol. 
335, pp. 879-883. 
Levy, M. M. & et al 1992, "SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions 
Conference.", Critical Care Medicine, vol. 31, pp. 1250-1256. 
Levy, R. J., Piel, D. A., ACton, P. D., & et al 2005, "Evidence of myocardial hibernation in the 
septis subject.", Critical Care Medicine, vol. 33, pp. 2752-2756. 
Lucas, S. B. 2007, "The autopsy pathology of sepsis-related death", Current Diagnostic 
Pathology, vol. 13, pp. 375-388. 
Lucas, S. B. 2011, "Saving Mothers' Lives: Sepsis in pregnancy. Annex 7.1. A possible future 
approach to case definitions.", British Journal of Obstetrics and Gynaecology, vol. 118, 
no. supplement 1, March 2011, pp. 97-101. 
Mitchell, R. N. 2005, "Hemodynamic disorders, Thromboembolic disease, and Shock.," in 
Robbins and Contran Pathologic Basis of Disease, 7 edn, V. Kumar, A. K. Abbas, & N. 
Fausto, eds., Elsevier Saunders, Philadelphia, pp. 119-144. 
Moreillon, P., Que, Y.-A., & Glauser, M. P. 2005, "Staphylococcus aureus (including 
staphylococcal toxic shock)," in Mandell, Douglas, and Bennett's Principles and Practice 
of Infectious Diseases, 6 edn, G. L. Mandell, J. E. Bennet, & R. Dolin, eds., Elsevier 
Churchill Livingstone, Philadelphia, pp. 2321-2351. 
Morris, A., Masur, H., & Huang, L. 2006, "Current issues in critical care of the HIV-infected 
patient.", Critical Care Medicine, vol. 34, pp. 42-49. 
Morris, J. A., Harrison, L. M., & Partridge, S. M. 2006, "Postmortem bacteriology: a re-
evaluation", Journal of Clinical Pathology, vol. 59, no. 1, p. 9. 
Munford, R. S. 2005, "Sepsis, severe sepsis, and septic shock," in Mandell, Douglas and 
Bennett's Principles and Practice of Infectious Diseases, 6 edn, G. L. Mandell, J. E. 
Bennet, & R. Dolin, eds., Elsevier Churchill Livingstone, Pennsylvania, pp. 906-925. 
National Confidential Enquiry into Patient Outcome and Death 2006, The Coroner's Autopsy: 
Do we deserve better? www.ncepod.org.uk. 
Ningsanond, V. 2000, "Infection associated hemophagocytic syndrome: a report of 50 
children.", Journal of the Medical Association of Thailand, vol. 83, pp. 1141-1149. 
Nishida, N., Chiba, T., Ohtani, K., Ikeda, N., Katayama, Y., & Yoshioka, N. 2006, 
"Relationship between cardiopulmonary resuscitation and injuries of the cardiac 
conduction system: pathological features and pathogenesis of such injuries.", 
Critical Care Medicine, vol. 34, pp. 363-367. 
Perkins, G. D., McAuley, D. F., Davies, S., & Gao, F. 2003, "Discrepancies between clinical 
and postmortem diagnoses in critically ill patients: an observationsl study.", Critical 
Care, vol. 7, p. R129-R132. 
Racusen, L. & Kashgarian, M. 2007, "Ischemic and toxic acute tubular damage and other 
ischemic renal injury.," in Heptinstall's Pathology of the Kidney, 6 edn, J. C. Jennette et 
al., eds., Lippincott, Williams & Wilkins, Philadelphia, pp. 1139-1186. 
www.intechopen.com
 The Autopsy Pathology of Sepsis-Related Death 
 
99 
Recombinant human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study 
group. 2001, "Efficacy and safety of recombinant human activated protein C for 
severe sepsis.", New England Journal of Medicine, vol. 344, pp. 699-709. 
Riederman, N. C., Guo, R.-F., & Ward, P. A. 2003, "The enigma of sepsis.", Journal of Clinical 
Investigation, vol. 112, pp. 460-467. 
Rockey, D. C. & Bissell, M. 2006, "Non-invasive measures of liver fibrosis.", Hepatology, vol. 
43, p. S113-S120. 
Roosen, J., Frans, E., Wilmer, A., Knockaert, D. C., & Bobbaers, H. 2000, "Comparison of 
premortem clinical diagnoses in critically ill patients and subsequent autopsy 
findings.", Mayo Clin Proc, vol. 75, pp. 562-567. 
Royal College of Pathologists 2005, Sudden death with likely cardiac pathology www.rcpath.org. 
Scheuer, P. & Lefkowitch, J. H. 2006, "The liver in systemic disease and pregnancy," in Liver 
Biopsy Interpretation, 7 edn, Elsevier Saunders, pp. 331-332. 
Schnadig, V. J., Molina, C. P., & Aronson, J. F. 2007, "Cytodiagnosis in the autopsy suite: a 
tool for improving autopsy quality and resident education.", Arch Pathol Lab Med, 
vol. 131, pp. 1056-1062. 
Sharshar, T., Gray, F., de la Grandmaison, G. L., & et al 2003, "Apoptosis of neurons in 
cardiovascular autonomic centres triggered by inducible nitric oxide after death 
from septic shock.", Lancet, vol. 362, pp. 1799-1805. 
Singer, M., De Santis, V., Vitale, D., & Jeffcoate, W. 2004, "Multiorgan failure is an adaptive, 
endocrine-mediated, metabolic response to overwhelming systemic inflammation.", 
Lancet, vol. 364, pp. 545-548. 
Stauss, R., Neureiter, D., Westenburger, B., & et al 2004, "Multifactorial risk analysis of bone 
marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical 
patients - a postmortem clinicopathologic analysis.", Critical Care Medicine, vol. 32, 
pp. 1316-1321. 
Stebbing, J., Adams, C., Mletzko, S., & et al 2011, "Plasma HHV8 DNA predicts relapse in 
individuals with HIV-associated multicentric Castleman disease.", Blood, vol. 118, 
pp. 271-275. 
Takahashi, N., Chubachi, A., Kume, M., & et al 2001, "A clinical analysis of 52 adult patients 
with hemophagocytic syndrome: the prognostic significance of the underlying 
diseases.", International Journal of Haematology, vol. 74, pp. 209-213. 
Tissari, P., Zumla, A., Tarkka, E., & et al 2010, "Accurate and rapid identificatino of bacterial 
species from positive blood cultures with a DNA-based microarray platform: an 
observational study.", Lancet, vol. 375, pp. 224-230. 
Toh, C. H. & Dennis, M. 2003, "Disseminated intravascular coagulation: old disease, new 
hope", British Medical Journal, vol. 327, pp. 974-977. 
Tsokos, M. 2003, "Immunohistochemical detection of sepsis-induced lung injury in human 
autopsy material.", Legal Medicine, vol. 5, pp. 73-86. 
van der Poll.T & Opal, S. M. 2008, "Host-pathogen interactions in sepsis.", Lancet Infectious 
Diseases, vol. 8, pp. 32-43. 
Villar, J., Maca-Meyer, N., Perez-Mendez, L., & Flores, C. 2004, "Bench-to-bedside review: 
understanding genetic predisposition to sepsis.", Critical Care, vol. 8, pp. 180-189. 
Vincent, J. L. & Singer, M. 2010, "Critical care: advances and future prospects", Lancet, vol. 
376, pp. 1354-1361. 
www.intechopen.com
 Severe Sepsis and Septic Shock – Understanding a Serious Killer 
 
100 
Wheeler, A. P. & Bernard, G. R. 2007, "Acute lung injury and teh acute respiratory distress 
syndrome: a clinical review", Lancet, vol. 369, pp. 1553-1565. 
Whitwell, H. 2005, "Techniques.," in Forensic Neuropathology, H. Whitwell, ed., Hodder 
Arnold, London, pp. 20-35. 
Zhu, B. L., Ishikawa, T., Michiue, T., Quan, L., & Maeda, H. 2005, "Postmortem serum 
endotoxin level in reiation to the causes of death.", Legal Medicine, vol. 7, pp. 103-
109. 
www.intechopen.com
Severe Sepsis and Septic Shock - Understanding a Serious Killer
Edited by Dr Ricardo Fernandez
ISBN 978-953-307-950-9
Hard cover, 436 pages
Publisher InTech
Published online 10, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Despite recent advances in the management of severe sepsis and septic shock, this condition continues to be
the leading cause of death worldwide. Some experts usually consider sepsis as one of the most challenging
syndromes because of its multiple presentations and the variety of its complications. Various investigators from
all over the world got their chance in this book to provide important information regarding this deadly disease .
We hope that the efforts of these investigators will result in a useful way to continue with intense work and
interest for the care of our patients.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Sebastian Lucas (2012). The Autopsy Pathology of Sepsis-Related Death, Severe Sepsis and Septic Shock -
Understanding a Serious Killer, Dr Ricardo Fernandez (Ed.), ISBN: 978-953-307-950-9, InTech, Available
from: http://www.intechopen.com/books/severe-sepsis-and-septic-shock-understanding-a-serious-killer/the-
autopsy-pathology-of-sepsis-and-septic-shock
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
